EVLO
Evelo Biosciences, Inc.
Set alert
0.00 USD 0.00 0.00%
0.0005 Day range 0.0005
0.0001 52-week range 0.0005
- YTD
- -80.00%
- 1 year
- -80.00%
- Open
- 0.0005
- Prev close
- 0.0001
- Mkt cap
- 1.90K
- Vol
- 133
- Avg vol
- 2.65K
- EPS
- -3.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0005
- High
- 0.0005
- Forward P/E
- -0.03
- Beta
- 1.89
- Short ratio
- 0.12
- Inst. own
- 83.03%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 26, 2024
- 50-d avg
- 0.26256
- 200-d avg
- 3.43
- 1y target
- 10.00
Ownership
Held by insiders 0.16%
Held by institutions 83.03%
Float held by institutions 83.17%
Institutions 45
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Flagship Pioneering Inc. | 13.39% | 2,521,369 | 8.19M | Jun 29, 2023 |
| Michigan (State Of) Teachers Retirement System | 1.08% | 203,536 | 661.49K | Jun 29, 2023 |
| Credit Suisse Ag/ | 0.96% | 180,520 | 586.69K | Jun 29, 2023 |
| Vanguard Group Inc | 0.83% | 155,896 | 506.66K | Jun 29, 2023 |
| Harbourvest Partners, LLC | 0.81% | 153,175 | 497.82K | Jun 29, 2023 |
| FMR, LLC | 0.67% | 126,425 | 410.88K | Jun 29, 2023 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 0.56% | 104,548 | 339.78K | Jun 29, 2023 |
| iShares NASDAQ Biotechnology ETF | 0.35% | 66,186 | 437.49K | Aug 30, 2023 |
| Vanguard Extended Market Index Fund | 0.26% | 48,600 | 157.95K | Jun 29, 2023 |
| Fidelity Growth Company K6 Fund | 0.16% | 30,211 | 82.48K | May 30, 2023 |
| Variable Insurance Products Fund-Growth Portfolio | 0.12% | 23,345 | 154.31K | Aug 30, 2023 |
| Fidelity Capital Appreciation Fund | 0.10% | 18,970 | 198.62K | Jul 30, 2023 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BODMER MARK | Officer | Sale | Nov 7, 2023 | 25,732 |
| CARRIERE STEPHEN J | Officer | Sale | Jan 22, 2023 | 203 |
| DARZI LORD ARA | Director | Purchase | May 26, 2022 | 342,465 |
| EPSTEIN DAVID R | Director | Conversion of Exercise of derivative security | Jun 29, 2022 | 93,932 |
| FLAGSHIP VENTURES | Beneficial Owner of more than 10% of a Class of Security | Purchase | May 26, 2022 | 0 |
| GILL BALKRISHAN | Chief Executive Officer | Sale | Nov 7, 2023 | 17,758 |